Sistema de Salut de Catalunya
Institut Català de la Salut
[Mir-Bonafé JF] Department of Dermatology, Hospital Son Llàtzer, Palma, Spain. [Piquero-Casals J] Department of Aesthetic Dermatology and Laser, Dermik, Clínica Dermatológica Multidisciplinar, Barcelona, Spain. [Prudkin L, Delgado J, Santamaria Martínez J] Innovation and Development, ISDIN, Barcelona, Spain. [Garcia-Patos Briones V] Servei de Dermatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2024-04-02T10:09:28Z
2024-04-02T10:09:28Z
2024-03-18
Clobetasol; Scalp; Seborrheic dermatitis
Clobetasol; Cuir cabellut; Dermatitis seborreica
Clobetasol; Cuero cabelludo; Dermatitis seborreica
Background: Noninfectious inflammatory dermatoses of the scalp are common, and their symptomsin particular, those affecting appearance, can have a psychological effect that may be disproportionate to their clinical severity. Effective, cosmetically acceptable treatments are important to manage these conditions. Topical corticosteroids form the cornerstone of acute treatment for many of these conditions. We surveyed practicing dermatologists and dermatology residents to determine the current clinical practice in prescribing topical corticosteroids for these disorders in their various preparation formats. Methods: A Delphi method was used, consisting of 2 questionnaire rounds. The first round contained 34 questions and was completed by 612 dermatologists and dermatology residents via email. The first round of responses was analyzed, and points that had > 70% agreement were used to form a second questionnaire of 21 statements. This second round was completed by 346 participants, and their responses were used to generate a final report. Participants were practicing in both public and private practices. Results: Clobetasol propionate 0.05% topical solution was considered to be the most appropriate treatment for noninfectious inflammatory scalp dermatoses in general, with 75.1% agreement in the second round of questionnaire. The main advantages of clobetasol propionate over other topical corticosteroids were reported as potency, effectiveness, and broad action spectrum (94.8% agreement). The preferred pharmaceutical format was the solution of clobetasol propionate. Conclusion: Clobetasol propionate was the preferred topical treatment for the management of scalp dermatoses, usually as first-line treatment; solution was the preferred preparation.
Publication costs funded by ISDIN S.A.
Article
Published version
English
Enquestes; Decisió de grup; Pell - Malalties - Tractament; Cuir cabellut - Malalties - Tractament; Antiinflamatoris - Ús terapèutic; DISEASES::Skin and Connective Tissue Diseases::Skin Diseases::Scalp Dermatoses; CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Inflammatory Agents; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires; INFORMATION SCIENCE::Information Science::Systems Analysis::Delphi Technique; ENFERMEDADES::enfermedades de la piel y tejido conjuntivo::enfermedades de la piel::dermatosis del cuero cabelludo; COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinflamatorios; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios; CIENCIA DE LA INFORMACIÓN::Ciencias de la información::análisis de sistemas::técnica Delfos
Dove Medical Press
Clinical, Cosmetic and Investigational Dermatology;17
https://doi.org/10.2147/CCID.S448016
Attribution-NonCommercial 4.0 International
http://creativecommons.org/licenses/by-nc/4.0/
Articles científics - HVH [3439]
